In addition to paradoxical neurosarcoidosis, other neurological adverse events have been reported with the use of TNFα blockers such as multiple sclerosis [11], polycranial neuritis, chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy [12]. The gene discussed is TNF; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.